Efficacy of Anti Ectera drop in Treatment of neonatal Jaundice

Phase 3

• Conditions: KA87; eonatal jaundice.; Neonatal Hyperbilirubinaemia

• Registration Number: IRCT20201129049527N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

Parent’s consent to participate in the study
newborns with physiologic jaundice and need phototherapy treatment
Apgar score>7
No congenital & physical abnormalities

Exclusion Criteria

Any complications during the study
Incidence of G6PD in neonate
Incidence of infection in neonate

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Extent of jaundice. Timepoint: Before and after prescription of Anti Ectera drops. Method of measurement: ??? ?????????? ???? ?????.

Secondary Outcome Measures

Name	Time	Method
The need for phototherapy. Timepoint: Before and after prescription of Anti Ectera drops. Method of measurement: Laboratory testing of bilirubin and pediatrician diagnosis.